Pillstats
Rx only · Tablet, Coated · Oral

Pirfenidone

Brands: Esbriet · Pirfenidone

5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US16 NDCs
5 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)1592254
US makers6 labelers
Packages28
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.828$1.66$2.48$3.31Dec 2025Apr 2026Jul 2026
$1.521
Latest avg · Jul 22, 2026
-43%
Since Dec 17, 2025
5
Active US suppliers
62%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

244771942025 Q12025 Q22025 Q32025 Q42026 Q1
78
Rx · 2026 Q1
12K
Units dispensed
+333%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it5 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Alembic Pharmaceuticals Limitedunknown10SUPPLYING
Bryant Ranch Prepackrepackager6SUPPLYING
Exelan Pharmaceuticals, Inc.unknown4SUPPLYING
Cipla USA Inc.unknown4SUPPLYING
Legacy Pharma USA, Inc.unknown2SUPPLYING
Genentech, Inc.unknown2EXITED 2029

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.